门诊环境下测量重症后综合征结局的工具:专家共识与可行性现场测试结果
针对重症后综合征(PICS)诊断工具缺乏共识的问题,通过三轮半结构化专家共识流程(第一、二轮各14名来自9个利益相关组的参与者,第三轮6名临床研究者核心组细化),并结合ICU幸存者的探索性可行性调查(n1=5;n2=5;n3=7),提出了一套两步法PICS结局测量工具集。第一步筛查涵盖心理健康(PHQ-4)、认知(MiniCog、动物命名)、躯体功能(TUG、握力)和健康相关生活质量(EQ-5D-5L),并用单项条目测量ICU入住前后的主观健康。若患者报告ICU出院后新出现或加重的健康问题,且至少一项筛查测试显示相关损害,则进行第二步扩展评估,包括PHQ-8、GAD-7、IES-R、RBANS、TMT A和B、2-MWT、握力、SPPB、EQ-5D-5L和WHODAS 2.0。作者推荐所有ICU幸存者在门诊使用该第一步筛查,并随后转诊至专科医生,这可能提高对PICS的认识并减轻其负担。
要点
- 推荐所有ICU幸存者在门诊进行第一步筛查:心理健康用PHQ-4,认知用MiniCog和动物命名,躯体功能用TUG和握力,健康相关生活质量用EQ-5D-5L。
- 第一步筛查简短、免费,可由不同领域的医疗专业人员轻松实施。
- 若患者报告ICU出院后新出现或加重的健康问题,且至少一项筛查测试显示相关损害,则进行第二步扩展评估。
- 第二步扩展评估包括:心理健康用PHQ-8、GAD-7、IES-R;认知用RBANS、TMT A和B;躯体功能用2-MWT、握力、SPPB;健康相关生活质量用EQ-5D-5L、WHODAS 2.0。
- 该工具集结合了基于表现和患者报告的结局测量,第一步筛查后转诊至专科医生可能提高对PICS的认识并减轻其负担。
适用人群与场景
- 重症监护病房幸存者,在门诊环境中进行PICS结局测量。
诊断标准与关键阈值
- 第一步筛查阳性标准:患者报告ICU出院后新出现或加重的健康问题,且至少一项筛查测试显示相关损害,则进行第二步扩展评估。
处置流程与药物剂量
- 第一步筛查:心理健康采用患者健康问卷-4(PHQ-4);认知采用MiniCog和动物命名;躯体功能采用计时起立-行走测试(TUG)和握力;健康相关生活质量采用EQ-5D-5L;并用单项条目测量ICU入住前后的主观健康。
- 若第一步筛查阳性(报告新出现或加重的健康问题且至少一项筛查测试显示相关损害),则进行第二步扩展评估:心理健康采用患者健康问卷-8(PHQ-8)、广泛性焦虑障碍量表-7(GAD-7)、事件影响量表修订版(IES-R);认知采用可重复成套神经心理状态评估(RBANS)、连线测试(TMT)A和B;躯体功能采用2分钟步行试验(2-MWT)、握力、简易体能状况量表(SPPB);健康相关生活质量采用EQ-5D-5L、12条目世界卫生组织残疾评定量表(WHODAS 2.0)。
- 推荐所有ICU幸存者在门诊使用该工具集的第一步筛查,并随后转诊至专科医生。
研究设计与关键结果
- 通过三轮半结构化专家共识流程(第一轮和第二轮各有来自9个利益相关组的14名参与者,第三轮由6名临床研究者核心组细化最终提案),并结合ICU幸存者的探索性可行性调查(n1=5;n2=5;n3=7),提出了一套两步法PICS结局测量工具集。
证据类型、等级与局限
- 证据类型:专家共识与可行性现场测试。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者推荐所有ICU幸存者在门诊使用所建议工具集的第一步筛查,并随后转诊至专科医生;这可能提高对PICS的认识并减轻其负担。
指南或共识出处
- 指南名称:门诊环境下测量重症后综合征结局的工具——专家共识与可行性现场测试结果;发布机构:J Intensive Care Soc;年份:原文未提供。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There is no consensus on the instruments for diagnosis of post-intensive care syndrome (PICS). We present a proposal for a set of outcome measurement instruments of PICS in outpatient care.
METHODS: We conducted a three-round, semi-structured consensus-seeking process with medical experts, followed each by exploratory feasibility investigations with intensive care unit survivors (n1 = 5; n2 = 5; n3 = 7). Fourteen participants from nine stakeholder groups participated in the first and second consensus meeting. In the third consensus meeting, a core group of six clinical researchers refined the final outcome measurement instrument set proposal.
RESULTS: We suggest an outcome measurement instrument set used in a two-step process. First step: Screening with brief tests covering PICS domains of (1) mental health (Patient Health Questionnaire-4 (PHQ-4)), (2) cognition (MiniCog, Animal Naming), (3) physical function (Timed Up-and-Go (TUG), handgrip strength), and (4) health-related quality of life (HRQoL) (EQ-5D-5L). Single items measure subjective health before and after the intensive care unit stay. If patients report new or worsened health problems after intensive care unit discharge and show relevant impairment in at least one of the screening tests, a second extended assessment follows: (1) Mental health (Patient Health Questionnaire-8 (PHQ-8), Generalized Anxiety Disorder Scale-7 (GAD-7), Impact of Event Scale - revised (IES-R)); (2) cognition (Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), Trail Making Test (TMT) A and B); (3) physical function (2-Minute Walk Test (2-MWT), handgrip strength, Short Physical Performance Battery (SPPB)); and (4) HRQoL (EQ-5D-5L, 12-Item WHO Disability Assessment Schedule (WHODAS 2.0)).
CONCLUSIONS: We propose an outcome measurement instrument set used in a two-step measurement of PICS, combining performance-based and patient-reported outcome measures. First-step screening is brief, free-of-charge, and easily applicable by health care professionals across different sectors. If indicated, specialized healthcare providers can perform the extended, second-step assessment. Usage of the first-step screening of our suggested outcome measurement instrument set in outpatient clinics with subsequent transfer to specialists is recommended for all intensive care unit survivors. This may increase awareness and reduce the burden of PICS.
TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov (Identifier: NCT04175236; first posted 22 November 2019).
参考来源
- Spies CD, Krampe H, Paul N, et al. Instruments to measure outcomes of post-intensive care syndrome in outpatient care settings - Results of an expert consensus and feasibility field test. J Intensive Care Soc. 2020. PMID: 34025756. doi:10.1177/1751143720923597
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。